Abionyx Pharma (ABNX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | ||
| Income taxes - deferred | -37 | 42 |
| Other Working Capital | 1,619 | -5,963 |
| Other Operating Activity | -4,885 | -8,572 |
| Operating Cash Flow | $-3,303 | $-14,493 |
| Cash Flows From Investing Activities | ||
| PPE Investments | 1 | -8 |
| Investing Cash Flow | $1 | $-8 |
| Cash Flows From Financing Activities | ||
| Debt Repayment | 0 | -750 |
| Financing Cash Flow | $0 | $-750 |
| Exchange Rate Effect | 4 | -2 |
| Beginning Cash Position | 11,141 | 26,394 |
| End Cash Position | 7,843 | 11,141 |
| Net Cash Flow | $-3,302 | $-15,251 |
| Free Cash Flow | ||
| Operating Cash Flow | -3,303 | -14,493 |
| Capital Expenditure | -3 | -8 |
| Free Cash Flow | -3,306 | -14,501 |